Anaphylaxis: Recognition, Emergency Management, and Long-Term Prevention
Anaphylaxis is a severe, systemic, IgE-mediated (or non-IgE) hypersensitivity reaction that is rapid in onset and may cause death. Prompt recognition and intramuscular epinephrine are lifesaving.
Diagnostic Criteria (WAO/NSAID)
Anaphylaxis is highly likely when any ONE of three criteria is met:
- Acute onset (minutes–hours) with skin/mucosal involvement (hives, angioedema, flush) AND respiratory compromise (dyspnea, wheeze, stridor, hypoxia) OR reduced BP/end-organ dysfunction.
- Two or more of: skin/mucosal, respiratory, cardiovascular (hypotension, syncope), GI (cramp, vomiting) after likely allergen exposure.
- Reduced BP after known allergen exposure (systolic <90 mmHg or >30% drop from baseline).
Common Triggers
- Foods: peanut, tree nuts, shellfish, fish, milk, egg, wheat, soy, sesame (9th major allergen US 2023).
- Venom: Hymenoptera (bee, wasp, hornet, yellow jacket, fire ant).
- Medications: β-lactams, NSAIDs, biologics, NMBAs, radiocontrast.
- Latex, exercise (food-dependent exercise-induced anaphylaxis), idiopathic.
Emergency Treatment Algorithm
- Recognize → Call 911 → Epinephrine IM (anterolateral mid-thigh) 1:1000
- Adults: 0.3–0.5 mg (0.3–0.5 mL)
- Children: 0.01 mg/kg (max 0.3 mg); 0.15 mg auto-injector for 7.5–25 kg; 0.3 mg for >25 kg
- Supine position + leg elevation (if tolerated); left lateral if vomiting/pregnant.
- High-flow O₂; IV access; large-volume crystalloid bolus (20 mL/kg) if hypotensive.
- Adjuncts (AFTER epinephrine): H1 antihistamine (diphenhydramine 25–50 mg IV/IM), H2 blocker (famotidine 20 mg IV), corticosteroid (methylprednisolone 1–2 mg/kg IV) — for biphasic risk reduction, not acute reversal.
- Refractory: Epinephrine infusion (0.1–1 mcg/kg/min), vasopressors (norepinephrine), glucagon if on β-blocker.
- Observe 4–6+ hours (biphasic: 1–20%, peaks 8–12h); admit if severe, delayed presentation, poor access to care.
Long-Term Prevention
- Confirm Trigger: Allergist evaluation — history, skin prick/sIgE, component testing, oral challenge.
- Strict Avoidance: Label reading, cross-contact prevention, restaurant communication.
- Two EAIs at All Times: Replace before expiry; store 15–30°C.
- Written Anaphylaxis Action Plan: Share with school, work, caregivers.
- Medical ID: Bracelet/necklace/digital.
- Venom Immunotherapy: 95–98% protection for Hymenoptera allergy.
- Food OIT / Epicutaneous Immunotherapy: Emerging options for peanut, milk, egg (specialized centers).
- Alpha-gal Syndrome: Tick bite prevention; mammalian meat avoidance.
Special Populations
- Infants/Children: Weight-based dosing; AUVI-Q 0.1 mg for 7.5–15 kg.
- Pregnancy: Epinephrine safe; anaphylaxis risks fetal hypoxia.
- β-Blocker/ACEi Users: Refractory hypotension; glucagon 1–5 mg IV for β-blockade; avoid ACEi if history of angioedema.
Epinephrine FIRST, epinephrine FAST. No contraindication to epinephrine in anaphylaxis. Delay increases fatality risk.
Bulimia - Related Articles
- Hematemesis in Bulimia: A Medical Emergency
- Bulimia Nervosa: Core Features, Health Risks, and Evidence-Based Treatment
- Why Your Burps Smell: Gut Microbiome, Diet, and Red Flags
- Health Risks of Bulimia Nervosa: Medical and Psychiatric Consequences
- Understanding Bulimia Nervosa: Causes and Contributing Factors
- Bulimia Recovery: Setting Goals for Lasting Change
- Bulimia Nervosa: Physical Consequences of Purging Behaviors
